Tabugara, Ayessa A.
HRN: 38-34-22 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/28/2025
CEFTRIAXONE 1G (VIAL)
12/28/2025
12/28/2025
IV
1.2g
Now
TBI, Multiple Abrasions
Checking Initial Appropriateness